Norges Bank Neuronetics, Inc. Transaction History

Norges Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$2.84 - $4.52 $747,488 - $1.19 Million	-263,200 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$3.87 - $6.59 $1.02 Million - $1.73 Million	263,200 New	263,200 $1.17 Million
Q3 2021 Nov 14, 2022	BUY	$6.22 - $15.54 $1.64 Million - $4.09 Million	263,200 New	263,200 $1.73 Million
Q3 2021 Nov 05, 2021	SELL	$6.22 - $15.54 $1.35 Million - $3.37 Million	-216,600 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$10.15 - $17.25 $2.2 Million - $3.74 Million	216,600 New	216,600 $3.47 Million

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.